Primary Thyroid Lymphoma: A Rare Diagnosis Treated With Polatuzumab Vedotin

J Investig Med High Impact Case Rep. 2024 Jan-Dec:12:23247096241299566. doi: 10.1177/23247096241299566.

Abstract

Primary thyroid lymphoma is one of the rare and distinct type of extra nodal lymphomas originating within the thyroid gland. It accounts for less than 5% of all thyroid malignancies and 2% of extra nodal lymphomas. It predominantly affects older adults, with a higher incidence in women. Patients typically present with a rapidly enlarging thyroid mass, accompanied by clinical symptoms of compression such as dysphagia, dyspnea, and hoarseness. Diagnosis is established through a combination of fine-needle aspiration, core needle biopsy, and advanced imaging techniques. Standard treatment involves a multimodal strategy of chemotherapy, often with the addition of radiotherapy and surgical intervention. Herein presented is the first reported case of diffuse large B-cell lymphoma treated with Pola-R-CHP.

Keywords: Pola-R-CHP; chemotherapy for primary thyroid lymphoma; primary diffuse large B-cell lymphoma.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antibodies, Monoclonal
  • Antineoplastic Agents, Immunological / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biopsy, Fine-Needle
  • Female
  • Humans
  • Immunoconjugates / therapeutic use
  • Lymphoma, Large B-Cell, Diffuse* / diagnosis
  • Lymphoma, Large B-Cell, Diffuse* / drug therapy
  • Lymphoma, Large B-Cell, Diffuse* / pathology
  • Middle Aged
  • Thyroid Neoplasms* / drug therapy
  • Thyroid Neoplasms* / pathology

Substances

  • polatuzumab vedotin
  • Immunoconjugates
  • Antineoplastic Agents, Immunological
  • Antibodies, Monoclonal